...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Epigenetics and China-Based Newsoara Biopharma Announce Licensing Agreement for ZEN-3694

Just a further thought on this. So Don said he needed to put a few elements into place before going public. He then delivered on Pfizer with the TNBC x zen3694 trial and also, last year at the AGM he said he was headed to China after the meeting to put something in place and he said it takes a little extra time to get things done in China.

Of course what I was hoping for was a sale or CVR or some basis to get some revenue and only part of of that happened.

But given what has happened, both very positive, I wonder if liquidity might be an option now. I've stated my wish to Sarah and she passed it to management before these financing happened. If you are in the send camp as me let Zenith know.

I just want to sell a few shares and then stay long on the balance.

GLTA

Toinv

Share
New Message
Please login to post a reply